Skip to main content

HK2 KO cell lysate available now. KO validated by Next Generation Sequencing. Free of charge wild type control included. Knockout achieved by CRISPR/Cas9 X = 5 bp deletion Frameshift: 99%.

Be the first to review this product! Submit a review

Images

Western blot - Human HK2 (Hexokinase II) knockout HEK-293 cell lysate (AB281353), expandable thumbnail
  • Next Generation Sequencing - Human HK2 (Hexokinase II) knockout HEK-293 cell lysate (AB281353), expandable thumbnail

Key facts

Cell type
HEK-293
Species or organism
Human
Tissue
Kidney
Knockout validation
Next Generation Sequencing
Mutation description
Knockout achieved by CRISPR/Cas9 X = 5 bp deletion Frameshift: 99%

Alternative names

DKFZp686M1669, HK 2, HK II, HXK2_HUMAN, Hexokinase 2 muscle, Hexokinase type II, Hexokinase-2, Muscle form hexokinase

What's included?

1 Kit
Components
Human HK2 knockout HEK-293 cell lysate
1 x 100 µg
Human wild-type HEK-293 cell lysate
1 x 100 µg

Recommended products

HK2 KO cell lysate available now. KO validated by Next Generation Sequencing. Free of charge wild type control included. Knockout achieved by CRISPR/Cas9 X = 5 bp deletion Frameshift: 99%.

Key facts

Cell type
HEK-293
Mutation description
Knockout achieved by CRISPR/Cas9 X = 5 bp deletion Frameshift: 99%
Concentration
Loading...

Properties

Gene name
HK2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Next Generation Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Notes

Western blot data indicates that the CRISPR gene edit may have resulted in a truncation of the protein of interest. Please see data images.

Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com